Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald E Rose

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Gastroenterology|October 19, 2005
A dose-ranging study of the efficacy and tolerability of entecavir in Lamivudine-refractory chronic hepatitis B patientsTing-Tsung Chang, Robert G Gish, Stephanos J Hadziyannis, et al.
Antimicrobial Agents and Chemotherapy|September 3, 2025
Preclinical virology profiles of the HIV-1 capsid inhibitors VH4004280 and VH4011499Chunfu Wang, Haichang Huang, Lourdes Valera, et al.
Antimicrobial Agents and Chemotherapy|December 21, 2006
Two-year assessment of entecavir resistance in Lamivudine-refractory hepatitis B virus patients reveals different clinical outcomes depending on the resistance substitutions presentDaniel J Tenney, Ronald E Rose, Carl J Baldick, et al.
Journal of Virology|September 13, 2003
Biochemical and genetic characterizations of a novel human immunodeficiency virus type 1 inhibitor that blocks gp120-CD4 interactionsQi Guo, Hsu-Tso Ho, Ira Dicker, et al.
Plos Pathogens|September 15, 2010
A novel small molecule inhibitor of hepatitis C virus entryCarl J Baldick, Michael J Wichroski, Annapurna Pendri, et al.
Plos One|August 11, 2012
High-throughput screening and rapid inhibitor triage using an infectious chimeric Hepatitis C virusMichael J Wichroski, Jie Fang, Betsy J Eggers, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Gastroenterology|October 19, 2005
A dose-ranging study of the efficacy and tolerability of entecavir in Lamivudine-refractory chronic hepatitis B patientsTing-Tsung Chang, Robert G Gish, Stephanos J Hadziyannis, et al.
Antimicrobial Agents and Chemotherapy|September 3, 2025
Preclinical virology profiles of the HIV-1 capsid inhibitors VH4004280 and VH4011499Chunfu Wang, Haichang Huang, Lourdes Valera, et al.
Antimicrobial Agents and Chemotherapy|December 21, 2006
Two-year assessment of entecavir resistance in Lamivudine-refractory hepatitis B virus patients reveals different clinical outcomes depending on the resistance substitutions presentDaniel J Tenney, Ronald E Rose, Carl J Baldick, et al.
Journal of Virology|September 13, 2003
Biochemical and genetic characterizations of a novel human immunodeficiency virus type 1 inhibitor that blocks gp120-CD4 interactionsQi Guo, Hsu-Tso Ho, Ira Dicker, et al.
Plos Pathogens|September 15, 2010
A novel small molecule inhibitor of hepatitis C virus entryCarl J Baldick, Michael J Wichroski, Annapurna Pendri, et al.
Plos One|August 11, 2012
High-throughput screening and rapid inhibitor triage using an infectious chimeric Hepatitis C virusMichael J Wichroski, Jie Fang, Betsy J Eggers, et al.
Pageof 2